Imogen Farrow
Imogen tracks uplistings, small IPOs, and exchange compliance across the micro-cap market, covering how the smallest issuers reach and keep senior listings.
Articles by Imogen Farrow
Stewards uplists from OTCID to the Nasdaq Capital Market with no offering and no new shares
The private-credit and real-assets company said Nasdaq's Listing Qualifications Department approved a direct uplisting from the OTCID Market with no concurrent public offering and no issuance of new shares, with trading under the symbol SWRD scheduled to begin on the Nasdaq Capital Market at Thursday's open. A summary of its June-quarter Form 10-Q shows a $7.236 million GAAP net loss, $136.1 million of total liabilities and a liquidity conclusion resting on a $24.0 million funding commitment from what the filing calls a related Stewards International fund.
Nuburu shares to resume NYSE American trading Sept. 14 after 1-for-40 reverse split
The exchange suspended the blue-laser maker's stock on July 17 under its low-selling-price rule and began delisting proceedings. A 1-for-40 reverse split effective Sept. 1 cut shares outstanding from roughly 370.5 million to about 9.3 million; it is the company's second reverse split of 2026.
Check-Cap Closes MBody AI Merger and $10 Million Share Sale; the Nasdaq Listing Now Trades as MBAI
The Israeli-registered listed vehicle has been renamed MBody AI Ltd. and moved to the ticker MBAI. About 81 percent of the roughly 15.3 million shares outstanding are restricted securities issued to the private company's former holders, and only a majority of that block is under lock-up.
GlobalTech's 1-for-3 Reverse Split Took Effect Thursday, Ahead of a Nasdaq Application Its Own Filing Says It Does Not Yet Meet All the Requirements For
The OTCQB-quoted company cut its share count from about 152 million to about 50 million, citing a Nasdaq Capital Market application that, by its own written account, it has not been approved for and does not currently meet all the requirements for.
American Fusion Cleared FINRA and OTC Markets in Four Days. Its June Quarterly Report Shows $79,341 in Cash, 1.62 Billion Shares and a Going-Concern Warning.
The fusion developer says OTCQB is a step toward a Nasdaq or Texas Stock Exchange listing. Its June quarter filing lists 2.45 billion potentially dilutive underlying shares against an authorized ceiling of 1.8 billion, and it has not announced an exchange application, a share consolidation or terms for the $50 million raise.
NuRAN's C$7.6 Million Nasdaq Financing Brought In C$3 Million of Cash. The Other C$4.6 Million Cleared Debt.
NuRAN Wireless says Nasdaq has approved its common shares for the Capital Market and that trading is expected to begin Monday under the ticker NUR. The preferred-share placement that closed after Friday's bell settled a convertible debenture, supplier bills and three executives' unpaid salaries.
The IPO market is raising record money while the smallest deals quietly disappear
Ninety-nine US IPOs have priced in 2026 against $145.3 billion raised, but the micro-cap end of the calendar has thinned to roughly a dozen deals as listing standards tighten.
BioStem Technologies Graduates to Nasdaq as the Small-Cap Listing Window Stays Open
The Florida tissue-allograft maker began trading on the Nasdaq Capital Market on August 7, joining a 2026 new-listings calendar that is running ahead of last year's pace.
First Phosphate Skips a Rung: ADR Uplisting Lands the LFP Developer on the Nasdaq Global Market
The Quebec-focused phosphate company moved its American Depositary Receipts from OTCQX to the Nasdaq Global Market on August 10 under the ticker PHOS — a cross-border listing route that raised no new capital and issued no new shares.